Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadine Jagerovic

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Pharmacology|June 20, 2019
Antitumor Cannabinoid Chemotypes: Structural InsightsPaula Morales, Nadine Jagerovic
Expert Opinion on Drug Discovery|April 28, 2020
Novel approaches and current challenges with targeting the endocannabinoid systemPaula Morales, Nadine Jagerovic
Advances in Experimental Medicine and Biology|February 4, 2021
Synthetic and Natural Derivatives of CannabidiolPaula Morales, Nadine Jagerovic
Current Medicinal Chemistry|April 26, 2016
Advances Towards The Discovery of GPR55 LigandsPaula Morales, Nadine Jagerovic
Biochemical Pharmacology|July 29, 2018
Emerging strategies targeting CB<sub>2</sub> cannabinoid receptor: Biased agonism and allosterismPaula Morales, Pilar Goya, Nadine Jagerovic
Current Topics in Medicinal Chemistry|February 22, 2008
CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applicationsNadine Jagerovic, Cristina Fernandez-Fernandez, Pilar Goya
Frontiers in Pharmacology|July 14, 2017
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of CannabidiolPaula Morales, Patricia H Reggio, Nadine Jagerovic
Cannabis and Cannabinoid Research|September 2, 2017
Allosteric Modulators of the CB<sub>1</sub> Cannabinoid Receptor: A Structural Update ReviewPaula Morales, Pilar Goya, Nadine Jagerovic, et al.
Expert Opinion on Therapeutic Patents|May 25, 2016
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent updatePaula Morales, Laura Hernandez-Folgado, Pilar Goya, et al.
Frontiers in Molecular Biosciences|March 14, 2022
Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual ModulatorsPaula Morales, Chanté Muller, Nadine Jagerovic, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Pharmacology|June 20, 2019
Antitumor Cannabinoid Chemotypes: Structural InsightsPaula Morales, Nadine Jagerovic
Expert Opinion on Drug Discovery|April 28, 2020
Novel approaches and current challenges with targeting the endocannabinoid systemPaula Morales, Nadine Jagerovic
Advances in Experimental Medicine and Biology|February 4, 2021
Synthetic and Natural Derivatives of CannabidiolPaula Morales, Nadine Jagerovic
Current Medicinal Chemistry|April 26, 2016
Advances Towards The Discovery of GPR55 LigandsPaula Morales, Nadine Jagerovic
Biochemical Pharmacology|July 29, 2018
Emerging strategies targeting CB<sub>2</sub> cannabinoid receptor: Biased agonism and allosterismPaula Morales, Pilar Goya, Nadine Jagerovic
Current Topics in Medicinal Chemistry|February 22, 2008
CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applicationsNadine Jagerovic, Cristina Fernandez-Fernandez, Pilar Goya
Frontiers in Pharmacology|July 14, 2017
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of CannabidiolPaula Morales, Patricia H Reggio, Nadine Jagerovic
Cannabis and Cannabinoid Research|September 2, 2017
Allosteric Modulators of the CB<sub>1</sub> Cannabinoid Receptor: A Structural Update ReviewPaula Morales, Pilar Goya, Nadine Jagerovic, et al.
Expert Opinion on Therapeutic Patents|May 25, 2016
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent updatePaula Morales, Laura Hernandez-Folgado, Pilar Goya, et al.
Frontiers in Molecular Biosciences|March 14, 2022
Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual ModulatorsPaula Morales, Chanté Muller, Nadine Jagerovic, et al.
Pageof 6